| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |